Top WTA Stars Weigh In on Tour’s New Genetic Sex Testing Policy
Most top players appear to have little issue with the tour’s decision.
Recent discussions around transgender athletes competing in women's sports have mainly focused on tennis, following the WTA's announcement in July to mandate genetic sex testing for all players. At the Montreal Open, several top WTA players shared their perspectives on the rule changes.
World No. 1 Aryna Sabalenka supported the WTA's decision, emphasizing the importance of maintaining fairness in women's tennis. She stated that men are biologically stronger than women, making it unfair for them to compete against biological women. The WTA's policy clarifies that the testing distinguishes between biological sex and gender identity, ensuring the policy's clarity and intended effects.
However, World No. 2 Elena Rybakina expressed less enthusiasm for the new policy. While she would follow the WTA's decision, she did not comment further on the necessity of the tests. Two-time Grand Slam champion Coco Gauff acknowledged the rationale behind the rule changes, calling for balance in the discourse surrounding transgender athletes. Gauff emphasized her support for the transgender community while also advocating for fairness in sports.
Jessica Pegula, the top-ranked American and WTA Players' Council member, reported that the decision was met with a generally positive response from players. She also mentioned that the WTA has provided players with detailed information about the policy's rationale and the testing process. Pegula believes the testing will begin at the Cincinnati Open, which starts next week.
The WTA's decision arrives months after the International Olympic Committee implemented a similar policy requiring all female athletes to undergo genetic sex testing to compete in the 2028 Summer Olympics.
Written by urgent.news from Front Office Sports's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
